(GRTS) – Corporate News
-
Gritstone bio (GRTS) Reports Publication of Interim Results from Phase 1/2 Study of “Off-the-Shelf” Neoantigen Vaccine Platform (SLATE)
-
Gritstone bio (GRTS) Prices $32.5M Share and Warrant Offering at $1.50/sh
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to GRTS Stock Lookup